Physician
Family Medicine
Dr. Michael R. Lebens, MD
|
|
Give Review
Michael Lebens is an expert in the field of Family Medicine. He went to University of Rochester School of Medicine and Dentistry. Michael Lebens has written publications. He has 24 publications published with PubMed. The lastest paper is: 'Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody respons...' Doctor Michael R. Lebens, MD is registered with Medicare.
Publications
- Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody respons...
- Evidence for several waves of global transmission in the seventh cholera pandemic.
- Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
- Crystal structures exploring the origins of the broader specificity of escherichia coli heat-labile enterotoxin compared to cholera toxin.
- Over-expression of major colonization factors of enterotoxigenic Escherichia coli, alone or together, on non-toxigenic E. coli bacteria.
- Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines.
- Carbohydrate binding specificities and crystal structure of the cholera toxin-like B-subunit from Citrobacter freundii.
- Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
- No direct binding of the heat-labile enterotoxin of Escherichia coli to E. coli lipopolysaccharides.
- CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.
- Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Escherichia coli.
- Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Escherichia coli colonization factor CS6.
- Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
- Mutations in the periplasmic chaperone leading to loss of surface expression of the colonization factor CS6 in enterotoxigenic Escherichia coli (ETEC) clinical isolates.
- Oral tolerance induction by mucosal administration of cholera toxin B-coupled antigen involves T-cell proliferation in vivo and is not affected by depletion of CD25+ T...
- The major subunit, CfaB, of colonization factor antigen i from enterotoxigenic Escherichia coli is a glycosphingolipid binding protein.
- Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA.
- In vivo adjuvant-induced mobilization and maturation of gut dendritic cells after oral administration of cholera toxin.
- Novel binding site identified in a hybrid between cholera toxin and heat-labile enterotoxin: 1.9 A crystal structure reveals the details.
- Current status and future prospects for a vaccine against schistosomiasis.
- A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection.
- The nptA gene of Vibrio cholerae encodes a functional sodium-dependent phosphate cotransporter homologous to the type II cotransporters of eukaryotes.
- Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo.
Schools
University Of Rochester
St Joseph Hospital
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- CaliforniaCare HMO
- Advantage Preferred DirectAccess Plus PPO
- Blue Cross Blue Shield of California PPO
- Pathway X Direct Access PPO
- Pathway X Tiered Direct Access
- Select Plus HMO
- Select PPO
- Access Plus Savenet
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Covered California - Bronze PPO
- Health Net PPO
- Individual and Family PPO
- Humana
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Education
-
Exempla St Joseph Hospital -
University of Rochester School of Medicine and Dentistry
Drug Facts
| NPI NUMBER | 1023225836 | |
| NPPES Provider LastName | LEBENS | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 934654056 | |
| NPPES Provider State | CA | |
| Specialty Description | Family Practice | |
| Total Claim Count | 2363.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 84.0 | |
| Percent Opioid Claims | 3.55 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023225836 |
| Last Name Of The Provider | LEBENS |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Hendrik F. Breytenbach, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janice C. Ortiz, MD |
|
|
Dr. Todd F. Lomelino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexander F. Castellanos, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Anthony, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Terri Carlson, MD |
|
|
Dr. Denis M. Perry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Klyda J. White, DO
This Doctor is OpenDoctor Recommended.
|